Literature DB >> 2097155

Estrogen and progestin receptor levels in uterine leiomyomata: relation to the tumour histology and the phase of menstrual cycle.

S Chrapusta1, W Sieinski, B Konopka, J Szamborski, Z Paszko.   

Abstract

Estrogen receptor (ER) and progestin receptor (PR) levels in the myometria and uterine leiomyomata of 26 normally menstruating women were studied. No significant menstrual cycle-related change in ER level was found in the leiomyomata or normal myometria. The ER levels in normal myometria and in cellular leiomyomata, but not in usual leiomyomata, tended to be higher in the follicular phase than in the luteal one. The "cytosolic" PR levels in cellular leiomyomata and in usual leiomyomata with no or with slight hyalinization as well as in their parental myometria were significantly lower in the luteal than in the follicular phase. This was not the case in usual leiomyomata with more intense hyalinization. The findings show that the reactivity of uterine leiomyomata to estrogens and/or progestins may be related to the histological features of the tumors. This should be realized when studying the steroid receptor levels in the tumours and possibly also when planning an endocrine therapy for the leiomyomata.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2097155

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  Anatomical variation of the oestrogen receptor in the non-neoplastic myometrium of fibromyomatous uteri.

Authors:  P A Richards; A J Tiltman
Journal:  Virchows Arch       Date:  1996-08       Impact factor: 4.064

2.  Effects of menopausal hormone therapy on uterine myoma in menopausal women.

Authors:  Ik Jin Chang; Gi Youn Hong; Young Lim Oh; Byoung Ryun Kim; Seong Nam Park; Hae-Hyeog Lee; Yong-Jin Na; Jeong Namkung
Journal:  J Menopausal Med       Date:  2013-12-27

3.  Effect of a selective progesterone receptor modulator on induction of apoptosis in uterine fibroids in vivo.

Authors:  Petr Horak; Michal Mara; Pavel Dundr; Kristyna Kubinova; David Kuzel; Robert Hudecek; Roman Chmel
Journal:  Int J Endocrinol       Date:  2012-07-16       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.